AIMCA
ACOR

Alberta Investment Management Corp (AIMCo)’s Acorda Therapeutics ACOR Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-163
Closed -$259K – 1025
2019
Q1 		$259K Buy
+163
New +$294K ﹤0.01% 831

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ACOR Position: Q2 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 163 shares — an estimated $259K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ACOR in Q1 2019 and held it in 1 quarter. The position peaked at $259K in Q1 2019. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 163 Acorda Therapeutics shares in Q2 2019, an estimated $259K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Acorda Therapeutics in Q1 2019 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Acorda Therapeutics position peaked at $259K in Q1 2019.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2019, filed 14 Aug 2019.